Allergan Receives FDA Approval for Zymaxid Ophthalmic Solution
Links shared publicly online about this topic.
- 1,156total visits
Allergan Receives FDA Approval for Zymaxid Ophthalmic Solution
View full resource at drugs.com
Tags: Eye Infection, Conjunctivitis, FDA, Allergan
Most Recently Shared on May 19, 2010 at 11:38 pm By:
Allergan Receives FDA Approval for Zymaxid Ophthalmic Solution - http://bit.ly/dndI0j
Zymaxid ophthalmic solution approved for bacterial conjunctivitis - ONA
oncologynurseadvisor.com — “The FDA has approved Allergan--™s Zymaxid (gatifloxacin ophthalmic solution) 0.5%, a topical fluoroquinolone, for the treatment of bacterial conjunctivitis caused by susceptible organisms.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 20, 2010 at 3:23 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Zymaxid ophthalmic solution approved for bacterial conjunctivitis http://goo.gl/fb/sDmLT
Zymaxid ophthalmic solution approved for bacterial conjunctivitis - MPR
empr.com — “The FDA has approved Allergan's Zymaxid (gatifloxacin ophthalmic solution) 0.5%, a topical fluoroquinolone, for the treatment of bacterial conjunctivitis caused by susceptible organisms.” View full resource at empr.com
Most Recently Shared on May 20, 2010 at 3:23 pm By:
Zymaxid ophthalmic solution approved for bacterial conjunctivitis: The FDA has approved Allergan's Zymaxid (gatifl... http://bit.ly/cjMmKJ
Zymaxid ophthalmic solution approved for bacterial conjunctivitis - MPR
empr.com — “The FDA has approved Allergan's Zymaxid (gatifloxacin ophthalmic solution) 0.5%, a topical fluoroquinolone, for the treatment of bacterial conjunctivitis caused by susceptible organisms.” View full resource at empr.com
Most Recently Shared on May 20, 2010 at 2:46 pm By:
MPR News: Zymaxid ophthalmic solution approved for bacterial conjunctivitis: The FDA has approved Allergan's Zymax... http://bit.ly/clFJJU
FDA approves ZYMAXID ophthalmic solution for treatment of bacterial conjunctivitis
news-medical.net — “Allergan, Inc. today announced that the United States Food and Drug Administration has approved ZYMAXID (gatifloxacin ophthalmic solution) 0.5%, a topical fluoroquinolone anti-infective indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms; Haemophilus influenzae, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus mitis group, Streptococcus oralis, Streptococcus pneumonia.” View full resource at news-medical.net
Most Recently Shared on May 20, 2010 at 8:27 am By:
Obesity News: FDA approves ZYMAXID ophthalmic solution for treatment of bacterial conjunctivitis: Allergan, Inc.... http://twurl.nl/fcuc3y
Allergan Receives FDA Approval for Acuvail Ophthalmic Solution for the Treatment of Pain and Inflammation Following Cataract Surgery
drugs.com — “Acuvail (ketorolac tromethamine ophthalmic solution) is used to treat pain and inflammation following cataract surgery. Includes Acuvail side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on July 24, 2009 at 12:17 am By:
FDA Approves Acuvail Ophthalmic Solution - http://bit.ly/q8Fek
Advertisement
